| 1 | [SID103176198] | Active | IC50 | 9 | Inhibition of human recombinant HDAC3 [AID569930, Type: Literature] | Histone deacetylase 3 [gi:3334210] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Active | | IC50 | 9 [uM] | | BioAssay | Inhibition of human recombinant HDAC3 | | AID | 569930 | | BioAssay type | Literature | | Target | Histone deacetylase 3 [gi:3334210] | | PubMed | 21874153 | | Data Table |  |
|
| 2 | [SID103176198] | Active | IC50 | 9 | Inhibition of human recombinant HDAC3 [AID569930, Type: Literature] | Histone deacetylase 3 [gi:3334210] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Active | | IC50 | 9 [uM] | | BioAssay | Inhibition of human recombinant HDAC3 | | AID | 569930 | | BioAssay type | Literature | | Target | Histone deacetylase 3 [gi:3334210] | | PubMed | 21874153 | | Data Table |  |
|
| 3 | [SID103176198] | Active | IC50 | 12 | Inhibition of human recombinant HDAC2 [AID569929, Type: Literature] | Histone deacetylase 2 [gi:68068066] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Active | | IC50 | 12 [uM] | | BioAssay | Inhibition of human recombinant HDAC2 | | AID | 569929 | | BioAssay type | Literature | | Target | Histone deacetylase 2 [gi:68068066] | | PubMed | 21874153 | | Data Table |  |
|
| 4 | [SID103176198] | Active | IC50 | 15 | Inhibition of human recombinant HDAC8 [AID569931, Type: Literature] | Histone deacetylase 8 [gi:29839394] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Active | | IC50 | 15 [uM] | | BioAssay | Inhibition of human recombinant HDAC8 | | AID | 569931 | | BioAssay type | Literature | | Target | Histone deacetylase 8 [gi:29839394] | | PubMed | 21874153 | | Data Table |  |
|
| 5 | [SID103176198] | Active | IC50 | 16 | Inhibition of human recombinant HDAC1 [AID569928, Type: Literature] | Histone deacetylase 1 [gi:2498443] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Active | | IC50 | 16 [uM] | | BioAssay | Inhibition of human recombinant HDAC1 | | AID | 569928 | | BioAssay type | Literature | | Target | Histone deacetylase 1 [gi:2498443] | | PubMed | 21874153 | | Data Table |  |
|
| 6 | [SID103176198] | Active | | | Increase in ROS production in human U251 cells at 100 uM after 4 hrs by FACS [AID347396, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Active | | BioAssay | Increase in ROS production in human U251 cells at 100 uM after 4 hrs by FACS | | AID | 347396 | | BioAssay type | Literature | | Target | | | PubMed | 19007111 | | Data Table |  |
|
| 7 | [SID103176198] | Active | | | Increase in ROS production in human U251 cells at 100 uM after 4 hrs by FACS in presence of N-acetyl-L-cysteine [AID347397, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Active | | BioAssay | Increase in ROS production in human U251 cells at 100 uM after 4 hrs by FACS in presence of N-acetyl-L-cysteine | | AID | 347397 | | BioAssay type | Literature | | Target | | | PubMed | 19007111 | | Data Table |  |
|
| 8 | [SID103176198] | Active | | | Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR [AID412897, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Active | | BioAssay | Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR | | AID | 412897 | | BioAssay type | Literature | | Target | | | PubMed | 19053749 | | Data Table |  |
|
| 9 | [SID103176198] | Active | | | Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry [AID412899, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Active | | BioAssay | Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry | | AID | 412899 | | BioAssay type | Literature | | Target | | | PubMed | 19053749 | | Data Table |  |
|
| 10 | [SID74110] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1 [AID220, Type: other] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 74110 | | CID | 264 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1 | | AID | 220 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID103176198] | Active | | | Inhibition of 26S proteasome activity in human U251 cells at 0.5 mM after 24 hrs [AID347410, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Active | | BioAssay | Inhibition of 26S proteasome activity in human U251 cells at 0.5 mM after 24 hrs | | AID | 347410 | | BioAssay type | Literature | | Target | | | PubMed | 19007111 | | Data Table |  |
|
| 12 | [SID103176198] | Unspecified | Ki | 81.283 | Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr [AID360149, Type: Literature] | Solute carrier family 22 member 20 [gi:56404586] |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | Ki | 81.283 [uM] | | BioAssay | Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr | | AID | 360149 | | BioAssay type | Literature | | Target | Solute carrier family 22 member 20 [gi:56404586] | | PubMed | 17553798 | | Data Table |  |
|
| 13 | [SID103176198] | Unspecified | IC50 | 250 | Concentration required to inhibit the colony formation of pancreatic human (PACA) cell lines by 50% [AID154429, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 250 [uM] | | BioAssay | Concentration required to inhibit the colony formation of pancreatic human (PACA) cell lines by 50% | | AID | 154429 | | BioAssay type | Literature | | Target | | | PubMed | 10956204 | | Data Table |  |
|
| 14 | [SID103176198] | Unspecified | ED50 | 285 | In vitro for the differentiation induction activity determined in the human myeloid leukemic cell line HL-60 [AID81291, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | ED50 | 285 [uM] | | BioAssay | In vitro for the differentiation induction activity determined in the human myeloid leukemic cell line HL-60 | | AID | 81291 | | BioAssay type | Literature | | Target | | | PubMed | 10956204 | | Data Table |  |
|
| 15 | [SID103176198] | Unspecified | IC50 | 850 | Concentration required for 50% proliferation inhibition of myelomonocytic WEHI cell line [AID217956, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 850 [uM] | | BioAssay | Concentration required for 50% proliferation inhibition of myelomonocytic WEHI cell line | | AID | 217956 | | BioAssay type | Literature | | Target | | | PubMed | 1542095 | | Data Table |  |
|
| 16 | [SID103176198] | Unspecified | IC50 | 932 | Cytotoxicity against human U251 cells after 72 hrs by Hoechst test [AID347392, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 932 [uM] | | BioAssay | Cytotoxicity against human U251 cells after 72 hrs by Hoechst test | | AID | 347392 | | BioAssay type | Literature | | Target | | | PubMed | 19007111 | | Data Table |  |
|
| 17 | [SID103176198] | Unspecified | IC50 | 933 | Inhibitory activity on growth of B16F10.9 melanoma cell line [AID41062, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 933 [uM] | | BioAssay | Inhibitory activity on growth of B16F10.9 melanoma cell line | | AID | 41062 | | BioAssay type | Literature | | Target | | | PubMed | 1542095 | | Data Table |  |
|
| 18 | [SID103176198] | Unspecified | IC50 | 1000 | Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50% [AID3329, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 1000 [uM] | | BioAssay | Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50% | | AID | 3329 | | BioAssay type | Literature | | Target | | | PubMed | 10956204 | | Data Table |  |
|
| 19 | [SID103176198] | Unspecified | IC50 | 1525 | Concentration required for 50% proliferation inhibition of human promyelocytic HL-60 cell line [AID81447, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 1525 [uM] | | BioAssay | Concentration required for 50% proliferation inhibition of human promyelocytic HL-60 cell line | | AID | 81447 | | BioAssay type | Literature | | Target | | | PubMed | 1542095 | | Data Table |  |
|
| 20 | [SID103176198] | Unspecified | IC50 | 2000 | Inhibition of human recombinant HDAC7 [AID569934, Type: Literature] | Histone deacetylase 7 [gi:30913097] |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 2000 [uM] | | BioAssay | Inhibition of human recombinant HDAC7 | | AID | 569934 | | BioAssay type | Literature | | Target | Histone deacetylase 7 [gi:30913097] | | PubMed | 21874153 | | Data Table |  |
|
| 21 | [SID103176198] | Unspecified | IC50 | 2000 | Inhibition of human recombinant HDAC5 [AID569933, Type: Literature] | Histone deacetylase 5 [gi:296434519] |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 2000 [uM] | | BioAssay | Inhibition of human recombinant HDAC5 | | AID | 569933 | | BioAssay type | Literature | | Target | Histone deacetylase 5 [gi:296434519] | | PubMed | 21874153 | | Data Table |  |
|
| 22 | [SID103176198] | Unspecified | IC50 | 2000 | Antiproliferative activity against human K562 cells [AID416474, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 2000 [uM] | | BioAssay | Antiproliferative activity against human K562 cells | | AID | 416474 | | BioAssay type | Literature | | Target | | | PubMed | 18571290 | | Data Table |  |
|
| 23 | [SID103176198] | Unspecified | IC50 | 2000 | Inhibition of human recombinant HDAC9 [AID569935, Type: Literature] | Histone deacetylase 9 [gi:19865267] |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 2000 [uM] | | BioAssay | Inhibition of human recombinant HDAC9 | | AID | 569935 | | BioAssay type | Literature | | Target | Histone deacetylase 9 [gi:19865267] | | PubMed | 21874153 | | Data Table |  |
|
| 24 | [SID103176198] | Unspecified | IC50 | 2000 | Inhibition of human recombinant HDAC4 [AID569932, Type: Literature] | Histone deacetylase 4 [gi:259016348] |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 2000 [uM] | | BioAssay | Inhibition of human recombinant HDAC4 | | AID | 569932 | | BioAssay type | Literature | | Target | Histone deacetylase 4 [gi:259016348] | | PubMed | 21874153 | | Data Table |  |
|
| 25 | [SID103176198] | Unspecified | IC50 | 2000 | Inhibition of human recombinant HDAC6 [AID569936, Type: Literature] | Histone deacetylase 6 [gi:205371758] |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 2000 [uM] | | BioAssay | Inhibition of human recombinant HDAC6 | | AID | 569936 | | BioAssay type | Literature | | Target | Histone deacetylase 6 [gi:205371758] | | PubMed | 21874153 | | Data Table |  |
|
| 26 | [SID103176198] | Unspecified | IC50 | 2400 | Inhibition of cell growth against human myeloid leukemia K562(S) cells [AID95143, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 2400 [uM] | | BioAssay | Inhibition of cell growth against human myeloid leukemia K562(S) cells | | AID | 95143 | | BioAssay type | Literature | | Target | | | PubMed | 10560743 | | Data Table |  |
|
| 27 | [SID103176198] | Unspecified | Ki | 3467.37 | Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr [AID360150, Type: Literature] | Solute carrier family 22 member 6 [gi:81901833] |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | Ki | 3467.37 [uM] | | BioAssay | Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr | | AID | 360150 | | BioAssay type | Literature | | Target | Solute carrier family 22 member 6 [gi:81901833] | | PubMed | 17553798 | | Data Table |  |
|
| 28 | [SID103176198] | Unspecified | IC50 | 10000 | Inhibition of 2-oxoglutarate-dependent human JMJD2E in presence of excess 2-oxoglutarate and 10 uM Fe2 by FDH coupled assay [AID344916, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 10000 [uM] | | BioAssay | Inhibition of 2-oxoglutarate-dependent human JMJD2E in presence of excess 2-oxoglutarate and 10 uM Fe2 by FDH coupled assay | | AID | 344916 | | BioAssay type | Literature | | Target | | | PubMed | 18942826 | | Data Table |  |
|
| 29 | [SID103176198] | Unspecified | IC50 | 10000 | Inhibition of 2-oxoglutarate-dependent human JMJD2E in prescence of excess H3K9me3 peptide and 10 uM Fe2 by FDH coupled assay [AID344917, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | IC50 | 10000 [uM] | | BioAssay | Inhibition of 2-oxoglutarate-dependent human JMJD2E in prescence of excess H3K9me3 peptide and 10 uM Fe2 by FDH coupled assay | | AID | 344917 | | BioAssay type | Literature | | Target | | | PubMed | 18942826 | | Data Table |  |
|
| 30 | [SID103176198] | Unspecified | | | Inhibition of 26S proteasome activity in human U251 cells at 100 uM after 48 hrs relative to control [AID347412, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Inhibition of 26S proteasome activity in human U251 cells at 100 uM after 48 hrs relative to control | | AID | 347412 | | BioAssay type | Literature | | Target | | | PubMed | 19007111 | | Data Table |  |
|
| 31 | [SID103176198] | Unspecified | | | Inhibition of 26S proteasome activity in human U251 cells at 100 uM after 48 hrs in presence of N-acetyl-L-cysteine relative to control [AID347413, Type: Literature] | |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Inhibition of 26S proteasome activity in human U251 cells at 100 uM after 48 hrs in presence of N-acetyl-L-cysteine relative to control | | AID | 347413 | | BioAssay type | Literature | | Target | | | PubMed | 19007111 | | Data Table |  |
|
| 32 | [SID103176198] | Unspecified | | | Ratio of pKi for mouse Oat1 expressed in Xenopus oocytes to pKi for mouse Oat6 expressed in Xenopus oocytes [AID360151, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Ratio of pKi for mouse Oat1 expressed in Xenopus oocytes to pKi for mouse Oat6 expressed in Xenopus oocytes | | AID | 360151 | | BioAssay type | Literature | | Target | | | PubMed | 17553798 | | Data Table |  |
|
| 33 | [SID103176198] | Unspecified | | | Inhibition of erythroid differentiation in human K562 cell assessed benzidine positive cells at 2 mM after 6 days by benzidine staining assay [AID410585, Type: Literature] | |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Inhibition of erythroid differentiation in human K562 cell assessed benzidine positive cells at 2 mM after 6 days by benzidine staining assay | | AID | 410585 | | BioAssay type | Literature | | Target | | | PubMed | 19072686 | | Data Table |  |
|
| 34 | [SID103176198] | Unspecified | | | Protein interaction energy by using binding affinity towards human L-xylulose reductase enzyme [AID95754, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Protein interaction energy by using binding affinity towards human L-xylulose reductase enzyme | | AID | 95754 | | BioAssay type | Literature | | Target | | | PubMed | 12668014 | | Data Table |  |
|
| 35 | [SID103176198] | Unspecified | | | Evaluated for erythroid induction of benzidine-positive K562 cells at concentration 3 mM [AID94965, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Evaluated for erythroid induction of benzidine-positive K562 cells at concentration 3 mM | | AID | 94965 | | BioAssay type | Literature | | Target | | | PubMed | 10560743 | | Data Table |  |
|
| 36 | [SID103176198] | Unspecified | | | Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system [AID237685, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system | | AID | 237685 | | BioAssay type | Literature | | Target | | | PubMed | 15857133 | | Data Table |  |
|
| 37 | [SID103176198] | Unspecified | | | Inhibition of EBV-early antigen activation in human Raji cells assessed as early antigen activation at 4 mM [AID336938, Type: other] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Inhibition of EBV-early antigen activation in human Raji cells assessed as early antigen activation at 4 mM | | AID | 336938 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID103176198] | Unspecified | | | Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 4 mM ratio relative to TPA [AID336939, Type: other] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 4 mM ratio relative to TPA | | AID | 336939 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID103176198] | Unspecified | | | Partition coefficient (logP) (chloroform) [AID23254, Type: Literature] | |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) (chloroform) | | AID | 23254 | | BioAssay type | Literature | | Target | | | PubMed | 3599019 | | Data Table |  |
|
| 40 | [SID103176198] | Unspecified | | | Partition coefficient (logP) (ether) [AID23255, Type: Literature] | |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) (ether) | | AID | 23255 | | BioAssay type | Literature | | Target | | | PubMed | 3599019 | | Data Table |  |
|
| 41 | [SID103176198] | Unspecified | | | Partition coefficient (logP) (hexane) [AID23256, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) (hexane) | | AID | 23256 | | BioAssay type | Literature | | Target | | | PubMed | 3599019 | | Data Table |  |
|
| 42 | [SID103176198] | Unspecified | | | Effect on appearance of B16F10.9 colonies in semisolid agar at 1 mM [AID41060, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Effect on appearance of B16F10.9 colonies in semisolid agar at 1 mM | | AID | 41060 | | BioAssay type | Literature | | Target | | | PubMed | 1542095 | | Data Table |  |
|
| 43 | [SID103176198] | Unspecified | | | TP_TRANSPORTER: uptake of Butyric acid at a concentration of 137uM in MCT1-expressing MDA-MB231 cells [AID682070, Type: other] | Monocarboxylate transporter 1 [gi:1709076] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: uptake of Butyric acid at a concentration of 137uM in MCT1-expressing MDA-MB231 cells | | AID | 682070 | | BioAssay type | other | | Target | Monocarboxylate transporter 1 [gi:1709076] | | PubMed | | | Data Table |  |
|
| 44 | [SID103176198] | Unspecified | | | Specific activity of expressed human recombinant UGT1A10 [AID624613, Type: Literature] | UDP-glucuronosyltransferase 1-10 [gi:29839636] |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Specific activity of expressed human recombinant UGT1A10 | | AID | 624613 | | BioAssay type | Literature | | Target | UDP-glucuronosyltransferase 1-10 [gi:29839636] | | PubMed | 10836148 | | Data Table |  |
|
| 45 | [SID103176198] | Unspecified | | | Specific activity of expressed human recombinant UGT1A8 [AID624611, Type: Literature] | UDP-glucuronosyltransferase 1-8 [gi:29839637] |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Specific activity of expressed human recombinant UGT1A8 | | AID | 624611 | | BioAssay type | Literature | | Target | UDP-glucuronosyltransferase 1-8 [gi:29839637] | | PubMed | 10836148 | | Data Table |  |
|
| 46 | [SID103176198] | Unspecified | | | Increase in heme level in human U251 cells at 100 uM after 48 hrs by western blot relative to control [AID347403, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Increase in heme level in human U251 cells at 100 uM after 48 hrs by western blot relative to control | | AID | 347403 | | BioAssay type | Literature | | Target | | | PubMed | 19007111 | | Data Table |  |
|
| 47 | [SID103176198] | Unspecified | | | Toxicity in po dosed rat [AID498776, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Toxicity in po dosed rat | | AID | 498776 | | BioAssay type | Literature | | Target | | | PubMed | 19465932 | | Data Table |  |
|
| 48 | [SID103176198] | Unspecified | | | Toxicity in po dosed ICR mouse assessed as decreased in mobility after 3 hrs [AID498773, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Toxicity in po dosed ICR mouse assessed as decreased in mobility after 3 hrs | | AID | 498773 | | BioAssay type | Literature | | Target | | | PubMed | 19465932 | | Data Table |  |
|
| 49 | [SID103176198] | Unspecified | | | Induction of erythroid differentiation in human K562 cells assessed as benzidine-positive cells after 6 days [AID416475, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Induction of erythroid differentiation in human K562 cells assessed as benzidine-positive cells after 6 days | | AID | 416475 | | BioAssay type | Literature | | Target | | | PubMed | 18571290 | | Data Table |  |
|
| 50 | [SID103176198] | Unspecified | | | Partition coefficient (logP) [AID23251, Type: Literature] | |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103176198 | | CID | 264 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) | | AID | 23251 | | BioAssay type | Literature | | Target | | | PubMed | 3599019 | | Data Table |  |
|